Vimarsana
Biggest News Aggregation in the World

Page 3 - Run Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Run Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Run Capital Today - Breaking & Trending Today

PowerFleet (NASDAQ:PWFL) Coverage Initiated by Analysts at StockNews.com - Vimarsana News

PowerFleet (NASDAQ:PWFL) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of PowerFleet (NASDAQ:PWFL – Free Report) in a research report released on Thursday. The firm issued a hold rating on the stock. A number of other brokerages also recently issued reports on PWFL. Lake Street Capital reduced their price target on PowerFleet from $5.00 to $4.00 and set a buy […]

AbbVie (NYSE:ABBV) Releases Q3 Earnings Guidance - Vimarsana News

AbbVie (NYSE:ABBV) Releases Q3 Earnings Guidance

AbbVie (NYSE:ABBV – Get Free Report) updated its third quarter earnings guidance on Wednesday. The company provided earnings per share guidance of $2.76-2.86 for the period, compared to the consensus earnings per share estimate of $2.89. AbbVie also updated its FY 2023 guidance to $10.86-$11.06 EPS. Analysts Set New Price Targets A number of research […]

AbbVie (NYSE:ABBV) Updates Q3 2023 Earnings Guidance - Vimarsana News

AbbVie (NYSE:ABBV) Updates Q3 2023 Earnings Guidance

AbbVie (NYSE:ABBV – Get Free Report) issued an update on its third quarter 2023 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $2.76-$2.86 for the period, compared to the consensus estimate of $2.88. The company issued revenue guidance of -. AbbVie also updated its FY 2023 guidance to $10.86-$11.06 […]

AbbVie (NYSE:ABBV) Releases FY23 Earnings Guidance - Vimarsana News

AbbVie (NYSE:ABBV) Releases FY23 Earnings Guidance

AbbVie (NYSE:ABBV – Get Free Report) updated its FY23 earnings guidance on Wednesday. The company provided earnings per share guidance of $10.86-11.06 for the period, compared to the consensus earnings per share estimate of $11.07. AbbVie also updated its Q3 guidance to $2.76-2.86 EPS. Analyst Ratings Changes Several equities analysts have recently issued reports on […]

Constellium (NYSE:CSTM) Rating Increased to Buy at StockNews.com - Vimarsana News

Constellium (NYSE:CSTM) Rating Increased to Buy at StockNews.com

StockNews.com upgraded shares of Constellium (NYSE:CSTM – Free Report) from a hold rating to a buy rating in a report released on Wednesday morning. A number of other research analysts also recently commented on CSTM. JPMorgan Chase & Co. lowered their price target on shares of Constellium from $24.00 to $21.00 in a report on […]

Source: wkrb13.com